Stock info DaVita | Filter  Basic-Info

DaVita

The past year yielded positive returns for DaVita investors

Over the period from December 2015 till December 2016 the stock lost around 5 percent. The period between August 2011 and August 2016 was a good period for the investors. The stock rose around 75 percent. DaVita's revenues between 2011 and 2015 were very volatile through the time and moved between 8,19 billion dollars and 13,78 billion dollars. During 2011 and 2015 DaVita's net results were very volatile and fluctuated between 576,93 million dollars and 427,41 million dollars.

DaVita's head office is located in Denver. DaVita is mostly active in the health care eq. & services sector. DaVita is leaded by CEO Kent J. Thiry Carol Anthony Davidson leads the company as CFO. The period from 2006 till the end of 2016 the international sector gained around 102 percent. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-2016) there is a plus of 102 percent.

The American company didn't pay out any dividends (in the past 5 years).

DaVita' balance mostly consists of equity

At the end of 2015 the American company had a balance sheet of 18,51 billion dollars. Last year the total debt of the company was 13,64 billion dollars. This equals around 73,69 percent of the total balance sheet. At the end of 2016 the American company was traded with a price/earnings-ratio of around 23. So investors paid 23 times the company's 2015's EPS. Many analysts say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the health care company's market size (her number of outstanding share times the stock price) equaled around 14,38 billion dollars. At the end of 2015 the American company had around 209,75 million stocks listed on the exchanges.

All the company's financial reports are available here. More information about DaVita can be found it's website. .